The document provides an overview of the Indian pharmaceutical industry. It discusses the evolution of the industry through 5 phases from the early years to the current focus on innovation and research. Key points covered include the major players in the industry, drug trials conducted in India, medical tourism, moving up the value chain through generics and APIs, important pharmaceutical associations, and the future potential for growth in the retail segment and clinical trials outsourcing.

1. Industry Analysis: Pharma
Presented By:-
Neeraj Goswami
Prerna Agarwal
Ojaswi Katiyar
“The Indian pharmaceutical industry is a success
story providing employment for millions and
ensuring that essential drugs at affordable prices are
available to the vast population of this sub-
continent.”
Richard Gerster

2. Contents
1) Overview of Indian pharma.
2) Evolution of Indian Pharma.
3) Major players.
4) Drug Trial.
5) Medical tourism.
6) Moving up to the value chain.
7) Pharmaceutical-association in India.
8) Future scenario.
9) Pharma in news.

3. Indian Pharmaceutical Evolution
Phase II
Government Control
•Indian Patent Act –
1970
•Drug prices capped
•Local companies begin
to make an impact
Phase III
Development Phase
•Process
development
•Production
infrastructure
creation
•Export initiatives
Phase IV
Growth Phase
•Rapid expansion of
domestic market
•International market
development
•Research orientation
Phase V
Innovation and Research
•New IP law
•Discovery Research
•Convergence
1970 1980 1990 2000 2010
Phase I
Early Years
•Market share
domination by
foreign companies
•Relative absence
of organized Indian
companies

5. Drug Trial
• Phase-1
• Phase-2
• Phase-3
• Phase-4
Benefits:-
• Play an active role in their own health care.
• Gain access to new research treatments before they are widely available.
• Obtain expert medical care at leading health care facilities during the trial.
• Help others by contributing to medical research.
Risks:-
• There may be unpleasant, serious or even life-threatening side effects
to experimental treatment.
• The experimental treatment may not be effective for the participant.

6. Medical Tourism
• Cheaper medical and relaxation needs.
• Excellent infrastructure and technology in which is in
par with those in USA, UK and Europe.
• Some treatments which are best in India are:-
Eye Care
Dental Care
IVF Treatment
Heart Surgery & Heart Care
Health Check Up
Cosmetic Treatment
Orthopedic Surgery

7. Moving up the Value Chain
Specialty
Products
Innovative Products
TIME
Generic exports
to under-
developed &
developing
countries
Generic
exports to
developed
countries
API
Exports
VALUE

8. Pharmaceutical Associations
In IndiaIDMA CIPI-SSI
OPPI IPA
BDMA APTI

9. Indian Pharma Industry – Future
Scenario
• The Indian pharma industry is still trying to come to
terms with the new patent regime.
• Over the next 5 years, will continue to grow by at least
twice the rate of global growth.
• Retail segment will be the fastest growing segment.
• There will be a significant increase in the clinical trials
and diagnostics outsourcing.
• A significant window of opportunity will be available
expiring patents.

10. Pharma in News
• August 20, 2008: 49 babies die at leading
hospitals under drug trail process.
• Fight between Ranbaxy and Pfizer.(Lipitor)
• H1N1 vaccination available in Indian
Pharmaceutical market. (Nasovac)
• Aurobindo pharma and Astra-Zeneca to jointly
supply solid dosage in emerging market.

11. Biblograpahy
• www.pharmainfo.net
• www.fairdrugs.org
• www.ipapharma.org
• www.pharmabiz.com
• www.pharmaceutical-drug-
manufacturers.com
• www.medindia.net